Impulog Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). It serves as a nitrogen-free analogue of essential amino acids, designed to provide the necessary substrates for protein synthesis while minimizing nitrogenous waste production. This mechanism helps reduce the accumulation of uremic toxins and delays the progression of renal impairment. Impulog is typically administered alongside a low-protein diet to optimize nutritional status and preserve renal function in patients with moderate to severe CKD. The tablet supports metabolic balance by supplying ketoanalogues that are transaminated into essential amino acids, thereby reducing the burden on compromised kidneys. Clinical use of Impulog has demonstrated benefits in improving nutritional parameters, reducing azotemia, and potentially postponing the need for dialysis. It is important to use this medication under medical supervision, with regular monitoring of renal function and nutritional status. Contraindications include hypersensitivity to any component and caution is advised in patients with hepatic impairment. Impulog Tablet is a valuable adjunct in the comprehensive management of CKD, contributing to improved patient outcomes through nutritional optimization and renal protection.